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Summary and Implications 
 There are no approved drug treatments for analgesia use 
in lame swine, and the identification and validation of 
robust, repeatable pain measurements is fundamental for the 
development of effective analgesic drug regimens and 
management strategies for use in lame pigs. Induction of 
lameness allows for controlled evaluation of lameness pain 
in animals because pre- and post lameness measurements 
can be taken from the same animal, thereby reducing the 
confounding effects of individual differences. The objective 
of this study was to determine if a transient clinical 
lameness could be produced in sows using a distal 
interphalangeal joint space injection of Amphotericin B. Six 
clinically normal crossbred sows weighing approximately 
171 kg were purchased from a commercial producer in Iowa 
and housed in individual pens at Iowa State University. 
 Sows were randomly allotted to one of three treatments, 
two sows received 1 ml sterile saline control (CO), two 
sows received 10 mg amphotericin B in a 1 ml volume (LO) 
and two sows received 15 mg amphotericin B in a 1ml 
volume (HI). Sows were assessed for lameness while 
walking and standing based on a five point and data was 
collected using a GAITFour
®
 gait analysis walkway system. 
Data will be presented descriptively. All sows were scored 
as 0 at the onset of the trial for lameness. At 24 h post 
injection, the average lameness scores were 2.75, 2.00, and 
0.50 for the HI, LO and CO sows respectively. The CO 
sows’ average returned to 0 at 72 h post injection, HI sows’ 
average returned to 0 at 144 h, and LO sows’ average score 
returned to 0 at 192 h post injection 
 On the GAITFour system, the total number of sensors 
activated (SEN) decreased for the amphotericin treated feet 
suggesting a smaller footprint and pressure was shifted to 
the non-treated foot at 48 h post injection. These changes 
resolved by 144 h post injection. It was demonstrated using 
this “proof of concept” pilot study that injection of 10 or 15 
mg of amphotericin B in the distal interphalangeal joint of 
the medial claw of the rear foot causes clinical lameness in 
sows that is distinguishable from their pre-treatment gait by 
observational lameness score, and objective GAITFour 
measurement. Additionally, this lameness spontaneously 
resolved in this study by 192 h post injection.  
 
Introduction 
 Lameness has a significant impact on animal welfare 
and is therefore considered one of the most important causes 
of culling for sows in the United States. Furthermore, gilts 
and sows that exit the breeding herd prior to return on their 
economic inputs result in a net monetary loss for the farm. 
Science-based guidance for the industry on optimal housing, 
management and treatment of lame pigs is deficient. There 
are no approved drug treatments for analgesia use in lame 
swine, and the identification and validation of objective, 
repeatable pain measurements is fundamental for the 
development of effective analgesic drug regimens and 
management strategies for use in lame pigs (AVMA; 2010; 
FDA, 2010). Research to address the limited knowledge in 
this area is essential to formulating science-based 
recommendations for pig producers. This will become 
especially important if legislative actions succeed in 
preventing downed animals from entering the human food 
chain (Prevention of Farm Animal Cruelty Act and the 
Healthy School Meals Act) regardless of etiology. Most 
research has focused on behavioral or physiological changes 
associated with acute pain (Anil et al., 2002; Ting et al., 
2003; Stilwell et al., 2008), but these changes can be 
complex, with natural variation between animals 
complicating the differentiation of pain from other factors 
such as stress (Anderson and Muir, 2005). Induction of 
lameness allows for controlled evaluation of lameness pain 
in animals because pre- and post lameness measurements 
can be taken from the same animal, thereby reducing the 
confounding effects of individual differences. This approach 
has been published by Kotschwar et al., (2009). The authors 
concluded that the amphotericin B-induced synovitis-
arthritis model was a useful tool for studying changes 
associated with lameness in cattle through the use of 
pressure mats, heart rate and visual scoring of lameness. 
Therefore, the objective of this study was to determine if a 
transient clinical lameness could be produced in sows using 
a distal interphalangeal joint space injection of 
Amphotericin B. 
 
Materials and Methods 
 This project was approved by the ISU Animal Care and 
Use committee. 
 
Animals and housing: To avoid aggression, 6 clinically 
normal crossbred sows weighing approximately 171 kg 
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were purchased from a commercial producer in Iowa and 
housed in individual pens at Iowa State University. Each 
pen measured 3.7 m length x 1.4 m width x 1.2 m height. A 
rubber mat (2.5 m length x 2 cm height x 1.4 m width) was 
provided for sow comfort. Sows had ad libitum access to 
water via one nipple waterer that was positioned over a 
grate. Metal fences (1.9 m height x 76 cm width) were 
affixed at the end of each home pen and lights were on a 
12:12 light dark cycle (light hours were between 0600 and 
1800).  
 
Treatments: Sows were randomly allotted to one of three 
treatments, two sows received 1 ml sterile saline control 
(CO), two sows received 10 mg amphotericin B in a 1 ml 
volume (LO) and two sows received 15 mg amphotericin B 
in a 1 ml volume (HI). All injections were administered in 
the distal interphangeal joint of the medial claw of the rear 
foot while sows were anesthetized with Xylazine (2.2 
mg/kg), Ketamine (1.1 mg/kg), and Tiletamine (2.2 mg/kg) 
administered intramuscularly. Sows were monitored 
constantly post anesthesia until they returned to standing.  
 
Measures: At 24-h intervals, starting immediately prior to 
injection and anesthesia (Time 0), sows were assessed for 
lameness while walking and standing based on a five point 
scale (0 = animal moves freely and uses all four limbs/feet 
evenly to 4 = animal non-weight bearing on the affected 
limb when either standing or walking). Observations were 
made by two observers blinded to treatment and averaged at 
each timepoint. Additionally, sows were assessed using a 
GAITFour
®
 gait analysis walkway system and associated 
hardware. The GAITFour system is a high resolution, 4.3 m 
long, pressure sensitive mat originally designed for gait 
analysis in humans and later validated for dogs. It contains a 
matrix of 32,256 pressure sensors. These activities 
continued for 216 h post injection. Data will be presented 
descriptively.  
 
Results 
 All sows were scored as 0 at the onset of the trial for 
lameness. At 24 h post injection, the average lameness 
scores were 2.75, 2.00, and 0.50 for the HI, LO and CO 
sows respectively. The CO sows’ average returned to 0 at 72 
h post injection, HI sows’ average returned to 0 at 144 h, 
and LO sows’ average score returned to 0 at 192 h post 
injection (Figure 1). 
 
Figure 1. Average lameness scores by hours post 
injection and dose in sows injected intra-articularly with 
amphotericin B. 
 
On the GAITFour system, the total number of sensors 
activated (SEN) decreased for the amphotericin treated feet 
suggesting a smaller footprint and pressure was shifted to 
the non-treated foot at 48 h post injection as indicated in a 
change in DIFF max which was calculated as the difference 
in max pressure between the treated and untreated rear feet. 
These changes resolved by 144 h post injection (Table 1).  
 
Table 1. Objective Gait Analysis Parameters Means 
for the Investigation of Amphotericin B Induced 
Lameness in Sows (HI and LO treatments combined). 
 HPI** 
 0 48 144 
SEN count 30.6 26.9  29.7  
DIFF Max  8.16  -11.02  11.06  
**HPI = Hours Post Injection. 
SEN = number of sensors activated by amphotericin 
Treated foot on the pressure mat. 
DIFF = calculated difference between the MAX  
pressure of treated versus untreated rear feet. 
 
Conclusions 
 It was demonstrated using this “proof of concept” 
pilot study that injection of 10 or 15 mg of amphotericin 
B in the distal interphalangeal joint of the medial claw of 
the rear foot causes clinical lameness in sows that is 
distinguishable from their pre-treatment gait by 
observational lameness score, and objective GAITFour 
measurement. Additionally, this lameness spontaneously 
resolved in this study by 192 h post injection.  
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